IEEE Blockchain for Clinical Trials EU Forum Brings Focus on Empowering Patients
Summary
“Following our initial forum in February of this year, there’s been a growing consensus on the applicability of blockchain in the clinical trials space, explains Maria Palombini, director, Emerging Communities & Opportunities Development, IEEE-SA.Participants will play an active role in helping establish a roadmap towards overcoming the technical, regulatory, and industry challenges to blockchain adoption.Four viable use cases will be discussed, providing updates on progress while also exploring unresolved challenges where technical standards can help advance broader adoption of blockchain technology.Given the interactive nature of the Forum, seating is limited to passionate and committed industry professionals, advocates, policy makers and technologists who are seeking to advance and optimize drug development through patient empowerment and embracing innovation.Through its highly cited publications, conferences, technology standards, and professional and educational activities, IEEE is the trusted voice in a wide variety of areas ranging from aerospace systems, computers, and telecommunications to biomedical engineering, electric power, and consumer electronics.